Angiotensin receptors and their therapeutic implications

Annual Review of Pharmacology and Toxicology

Volumn 36, Issue , 1996, Pages 281-306

  Griendling, Kathy K ^a   Lassègue, Bernard ^a   Alexander, R Wayne ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AT1 receptors; AT2 receptors; gene expression; renin angiotensin system; vascular smooth muscle

Indexed keywords

1 (4 AMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDROIMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN ANTAGONIST; CANDESARTAN HEXETIL; CILAZAPRIL; LOSARTAN; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; RECEPTOR SUBTYPE;

ARTERY OCCLUSION; CARDIOVASCULAR DISEASE; HEART FAILURE; HEART HYPERTROPHY; HEART INFARCTION; HUMAN; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

AMINO ACID SEQUENCE; ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; BIPHENYL COMPOUNDS; CARDIOVASCULAR DISEASES; GENE EXPRESSION REGULATION; HUMANS; IMIDAZOLES; LOSARTAN; MOLECULAR SEQUENCE DATA; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM; STRUCTURE-ACTIVITY RELATIONSHIP; TETRAZOLES; TISSUE DISTRIBUTION;

EID: 0029904221     PISSN: 00664251     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (135)

1. Pfeffer MA, Braunwald E. 1990. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81: 1161-72
2. Tewksbury DA 1990. Angiotensinogen: Biochemistry and molecular biology. In Hypertension, Pathophysiology, Diagnosis and Management, ed. JH Laragh, BM Brenner, 75:1197-216. New York: Raven. 2360 pp.
3. Griendling KK, Lassègue B, Murphy TJ, Alexander RW. 1994. Angiotensin II receptor pharmacology. Adv. Pharmacol. 28:269-306
4. deGasparo M, Husain A, Alexander W, Catt KJ, Chiu AT, et al. 1995. Proposed update of angiotensin receptor nomenclature. Hypertension 25:924-27
5. Bumpus FM, Catt KJ, Chiu AT, deGasparo M, Goodfriend T, et al. 1991. Nomenclature for angiotensin receptors. A report of the Nomenclature Committee of the Council for High Blood Pressure Research. Hypertension 17:720-21
6. Chiu AT, Herblin WF, McCall DE, Ardecky RJ, Carini DJ, et al. 1989. Identification of angiotensin II receptor subtypes. Biochem. Biophys. Res. Commun. 165:196-203
7. Speth RC, Kim KH. 1990. Discrimination of two angiotensin-II receptor subtypes with a selective agonist analogue of angiotensin-II, p-aminophenylalanine6 angiotensin-II. Biochem. Biophys. Res. Commun. 169:997-1006
8. 2 receptors do not interact with guanine nucleotide binding proteins. Eur. J. Pharmacol. 207:157-63
9. Griendling KK, Alexander RW. 1990. Angiotensin, other pressors, and the transduction of vascular smooth muscle contraction. In Hypertension, Pathophysiology, Diagnosis and Management, ed. JH Laragh, BM Brenner, 38: 583-600. New York: Raven. 2360 pp.
10. 1 receptor subtype in the rat. Biochem. Biophys. Res. Commun. 192:1260-65
11. Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE. 1991. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 351:233-36
12. Sasaki K, Yamano Y, Bardhan S, Iwai N, Murray JJ, et al. 1991. Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature 351: 230-33
13. Bergsma DJ, Ellis C, Kumar C, Nuthulaganti P, Kersten H, et al. 1992. Cloning and characterization of a human angiotensin II type 1 receptor. Biochem. Biophys. Res. Commun. 183:989-95
14. Furuta H, Guo DF, Inagami T. 1992. Molecular cloning and sequencing of the gene encoding human angiotensin II type 1 receptor. Biochem. Biophys. Res. Commun. 183:8-13
15. Takayanagi R, Ohnaka K, Sakai Y, Nakao R, Yanase T, et al. 1992. Molecular cloning, sequence analysis and expression of a cDNA encoding human type-1 angiotensin II receptor. Biochem. Biophys. Res. Commun. 183:910-16
16. 1 angiotensin II receptor that is present in proximal tubule epithelium. Am. J. Physiol. 264:F645-54
17. Itazaki K, Shigeri Y, Fujimoto M. 1993. Molecular cloning and characterization of the angiotensin receptor subtype in porcine aortic smooth muscle. Eur. J. Pharmacol. 245:147-56
18. Sandberg K. 1994. Structural analysis and regulation of angiotensin II receptors. Trends Endocrinol. Metab. 5:28-35
19. Elton TS, Stephan CC, Taylor GR, Kimball MG, Martin MM, et al. 1992. Isolation of two distinct type I angiotensin II receptor genes. Biochem. Biophys. Res. Commun. 184:1067-73
20. Sasamura H, Hein L, Krieger JE, Pratt RE, Kobilka BK, Dzau VJ. 1992. Cloning, characterization, and expression of two angiotensin receptor (AT-1) isoforms from the mouse genome. Biochem. Biophys. Res. Commun. 185: 253-59
21. Iwai N, Inagami T. 1992. Identification of two subtypes in the rat type I angiotensin II receptor. FEBS Lett. 298: 257-60
22. Kakar SS, Sellers JC, Devor DC, Musgrove LC, Neill JD. 1992. Angiotensin II type-1 receptor subtype cDNAs: differential tissue expression and hormonal regulation. Biochem. Biophys. Res. Commun. 183:1090-96
23. Sandberg K, Ji H, Clark AJL, Shapira H, Catt KJ. 1992. Cloning and expression of a novel angiotensin II receptor subtype. J. Biol. Chem. 267: 9455-58
24. Desarnaud F, Marie J, Lombard C, Larguier R, Seyer R, et al. 1993. Deglycosylation and fragmentation of purified rat liver angiotensin II receptor: application to the mapping of hormone-binding domains. Biochem. J. 289:289-97
25. Su B, Martin MM, Beason B, Miller PJ, Elton TS. 1994. The genomic organization and functional analysis of the promoter for the human angiotensin II type 1 receptor. Biochem. Biophys. Res. Commun. 204:1039-46
26. Guo DF, Furuta H, Mizukoshi M, Inagami T. 1994. The genomic organization of human angiotensin-II type-1 receptor. Biochem. Biophys. Res. Commun. 200: 313-19
27. 1 angiotensin receptor. Biochem. Biophys. Res. Commun. 183:1025-32
28. 1a angiotensin receptor gene. Circ Res. 73: 612-21
29. 1B. Biochim. Biophys. Acta 1218:91-94
30. Takayanagi R, Ohnaka K, Sakai Y, Ikuyama S, Nawata H. 1994. Molecular cloning and characterization of the promoter for the human type-1 angiotensin II receptor gene. Biochem. Biophys. Res. Commun. 200:1264-70
31. Murasawa S, Matsubara H, Urakami M, Inada M. 1993. Regulatory elements that mediate expression of the gene for the angiotensin II type 1a receptor for the rat. J. Biol. Chem. 268:26996-7003
32. Uno S, Guo DF, Nakajima M, Ohi H, Imada T, et al. 1994. Glucocorticoid induction of rat angiotensin-II type 1A receptor gene promoter. Biochem. Biophys. Res. Commun. 204:210-15
33. Kakar SS, Riel KK, Neill JD. 1992. Differential expression of angiotensin II receptor subtype mRNAs (AT-1A and AT-1B) in the brain. Biochem. Biophys. Res. Commun. 185:688-92
34. Kitami Y, Okura T, Marumoto K, Wakamiya R, Hiwada K. 1992. Differential gene expression and regulation of type-1 angiotensin II receptor subtypes in the rat. Biochem. Biophys. Res. Commun. 188:446-52
35. 1A receptor couples with three different signal transduction pathways. Biochem. Biophys. Res. Commun. 186:1094-101
36. 1 receptor is tyrosine and serine phosphorylated and can serve as a substrate for the src family of tyrosine kinases. Biochem. Biophys. Res. Commun. 200:260-67
37. Marrero MB, Paxton WG, Duff JL, Berk BC, Bernstein KE. 1994. Angiotensin II stimulates tyrosine phosphorylation of phospholipase C-gamma 1 in vascular smooth muscle cells. J. Biol. Chem. 269:10935-39
38. Brock TA, Alexander RW, Ekstein LS, Atkinson WJ, Gimbrone MA Jr. 1985. Angiotensin increases cytosolic free calcium in cultured vascular smooth muscle cells. Hypertension 7: 1105-9
39. Griendling KK, Rittenhouse SE, Brock TA, Ekstein LS, Gimbrone MA Jr, Alexander RW. 1986. Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulated vascular smooth muscle cells. J. Biol. Chem. 261:5901-6
40. Lassègue B, Alexander RW, Clark M, Griendling KK. 1991. Angiotensin II-induced phosphatidylcholine hydrolysis in cultured vascular smooth-muscle cells. Regulation and localization. Biochem. J. 276:19-25
41. Tsuda T, Griendling KK, Ollerenshaw JD, Lassègue B, Alexander RW. 1993. Angiotensin II- and endothelin-induced protein phosphorylation in cultured vascular smooth muscle cells. J. Vasc. Res. 30:241-49
42. Simon MI, Strathmann MP, Gautam N. 1991. Diversity of G proteins in signal transduction, Science 252:802-8
43. Cockcroft S, Thomas GMH. 1992. Inositol-specific phospholipase C isoenzymes and their differential regulation by receptors. Biochem. J. 288:1-14
44. Socorro L, Alexander RW, Griendling KK. 1990. Cholera toxin modulation of angiotensin II-stimulated inositol phosphate production in cultured vascular smooth muscle cells. Biochem. J. 265: 799-807
45. Enyedi P, Mucsi I, Hunyady L, Catt KJ, Spät A. 1986. The role of guanyl nucleotide binding proteins in the formation of inositol phosphates in adrenal glomerulosa cells. Biochem. Biophys. Res. Commun. 140:941-47
46. Thompson NT, Garland LG, Bonser RW. 1993. Phospholipase D: regulation and functional significance. Adv. Pharmacol. 24:199-238
47. Wang P, Anthes JC, Siegel MI, Egan RW, Billah MM. 1991. Existence of cytosolic phospholipase D. J. Biol. Chem. 266:14877-80
48. Morducnowicz GA, Sheikh-Hamad D, Dwyer BE, Stern N, Jo OD, Yanagawa N. 1991. Angiotensin II directly increases rabbit renal brush-border membrane sodium transport: presence of local signal transduction system. J. Membr. Biol. 122:43-53
49. 2 in vascular smooth muscle cells. Biochem. J. 299:197-201
50. Schlondorff D, DeCandido S, Satriano JA. 1987. Angiotensin II stimulates phospholipases C and A2 in cultured rat mesangial cells. Am. J. Physiol. 253: C113-20
51. Pfeilschifter J, Bauer C. 1986. Pertussis toxin abolishes angiotensin II-induced phosphoinositide hydrolysis and prostaglandin synthesis in rat renal mesangial cells. Biochem. J. 236:289-94
52. Jard S, Cantau B, Jakobs KH. 1981. Angiotensin n and α-adrenergic agonists inhibit rat liver adenylate cyclase. J. Biol. Chem. 256:2603-6
53. Pobiner BF, Hewlett EL, Garrison JC. 1985. Role of Ni in coupling angiotensin receptors to inhibition of adenylate cyclase in hepatocytes. J. Biol. Chem. 260: 16200-9
54. Douglas JG, Romero M, Hopfer U. 1990. Signaling mechanisms coupled to the angiotensin receptor of proximal tubular epithelium. Kidney Int. Suppl. 30:S43-S47
55. Anand-Srivastava MB. 1989. Angiotensin II receptors negatively coupled to adenylate cyclase in rat myocardial sarcolemma. Involvement of inhibitory guanine nucleotide regulatory protein. Biochem. Pharmacol. 38:489-96
56. Langlois D, Bégeot M, Berthelon M-C, Jaillard C, Saez JM. 1992. Angioteasin II potentiates agonist-induced 3′,5′-cyclic adenosine monophosphate production by cultured bovine adrenal cells through protein kinase C and calmodulin pathways. Endocrinology 131:2189-95
57. Kubalak SW, Webb JG. 1993. Angiotensin II enhancement of hormone-stimulated cAMP formation in cultured vascular smooth muscle cells. Am. J. Physiol. 264:H86-H96
58. Tsuda T, Kawahara Y, Ishida Y, Koide M, Shii K, Yokoyama M. 1992. Angiotensin II stimulates two myelin basic protein/microtubule-associated protein 2 kinases in cultured vascular smooth muscle cells. Circ. Res. 71:620-30
59. Molloy CJ, Taylor DS, Weber H. 1993. Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells. J. Biol. Chem. 268:7338-45
60. Kai H, Griendling KK, Lassègue B, Ollerenshaw JD, Runge MS, Alexander RW. 1994. Agonist-induced phosphorylation of the vascular type 1 angiotensin II receptor. Hypertension 24:523-27
61. Griendling KK, Alexander RW. 1994. Renin-angiotensin system: cellular mechanisms of angiotensin II action. In Textbook of Hypertension, ed. JD Swales, 11:244-53. Oxford: Blackwell. 1328 pp.
62. Yamano Y, Obyama K, Chaki S, Guo DF, Inagami T. 1992. Identification of amino acid residues of rat angjotensin II receptor for ligand binding by site directed mutagenesis. Biochem. Biophys. Res. Commun. 187:1426-31
63. Gunther S. 1984. Characterization of angiotensin II receptor subtypes in rat liver. J. Biol. Chem. 259:7622-29
64. 1 receptor. J. Biol. Chem. 269:30953-59
65. Ji H, Sandberg K, Zhang Y, Can KJ. 1993. Molecular cloning, sequencing and functional expression of an amphibian angiotensin II receptor. Biochem. Biophys. Res. Commun. 131:75-86
66. Schambye HT, Hjorth SA, Bergsma DJ, Sathe G, Schwartz TW. 1994. Differentiation between binding sites for angiotensin II and nonpeptide antagonists on the angiotensin II type 1 receptors. Proc. Natl. Acad. Sci. USA 91: 7046-50
67. Ohyama K, Yamano Y, Chaki S, Kondo T, Inagami T. 1992. Domains for G-protein coupling in angiotensin II receptor type I: studies by site-directed mutagenesis. Biochem. Biophys. Res. Commun. 189:677-83
68. 1A receptor in CHO-K1 cells. J. Biol. Chem. 270:207-13
69. 1 angiotensin receptor. J. Biol. Chem. 269:31378-82
70. Hunyady L, Baukal AJ, Balla T, Catt KJ. 1994. Independence of type I angiotensin II receptor endocytosis from G protein coupling and signal transduction. J. Biol. Chem. 269:24798-804
71. 74 of the rat angiotensin II receptor confers changes in antagonist affinities and abolishes G-protein coupling. Proc. Natl. Acad. Sci. USA 90:5133-37
72. Gunther S, Gimbrone MA Jr, Alexander RW. 1980. Regulation by angiotensin II of its receptors in resistance blood vessels. Nature 287:230-32
73. Nickenig G, Murphy TJ. 1994. Down-regulation by growth factors of vascular smooth muscle angiotensin receptor gene expression. Mol. Pharmacol. 46: 653-59
74. Guo DF, Inagami T. 1994. Epidermal growth factor-enhanced human angiotensin-II type-1 receptor. Hypertension 23:1032-35
75. Tholanikunnel BG, Granneman JG, Malbon CC. 1995. The Mr 35,000 β-adrenergic receptor mRNA-binding protein binds transcripts of G-protein-linked receptors which undergo agonist-induced destabilization. J. Biol. Chem. 270:12787-93
76. Makita N, Iwai N, hiagami T, Badr KF. 1992. Two distinct pathways in the down-regulation of type-1 angiotensin II receptor gene in rat glomerular mesangial cells. Biochem. Biophys. Res. Commun. 185:142-46
77. Opperman M, Freedman NJ, Alexander RW, Lefkowitz RJ. 1995. Phosphorylation and desensitization of the type-1A angiotensin II receptor by protein kinase C and G-protein coupled receptor kinases. J. Biol. Chem. In press
78. Griendling KK, Delafontaine P, Rittenhouse SE, Gimbrone MA Jr, Alexander RW. 1987. Correlation of receptor sequestration with sustained diacylglycerol accumulation in angiotensin H-stimulated cultured vascular smooth muscle cells. J. Biol. Chem. 262:14555-62
79. Ullian ME, Unas SL. 1989. Role of receptor cycling in the regulation of angiotensin II surface receptor number and angiotensin II uptake in rat vascular smooth muscle cells. J. Clin. Invest. 84:840-46
80. Anderson KM, Murahashi T, Dostal DE, Peach MJ. 1993. Morphological and biochemical analysis of angiotensin II internalization in cultured rat aortic smooth muscle cells. Am. J. Physiol. 264:C179-88
81. Kambayashi Y, Bardhan S, Takahashi K, Tsuzuki S, Inui H, et al. 1993. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J. Biol. Chem. 268:24543-46
82. Chang RS, Lotti VJ. 1990. Two distinct angiotensin II receptor binding sites in rat adrenal revealed by new selective nonpeptide ligands. Mol. Pharmacol. 37:347-51
83. Mukoyama M, Nakajima M, Horiuchi M, Sasamura H, Pratt RE, Dzau VJ. 1993. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J. Biol. Chem. 268:24539-42
84. Martin MM, Su B, Elton TS. 1994. Molecular cloning of the human angiotensin II type 2 receptor cDNA. Biochem. Biophys. Res. Commun. 205: 645-51
85. Nakajima M, Mukoyama M, Pratt RE, Horiuchi M, Dzau VJ. 1993. Cloning of cDNA and analysis of the gene for mouse angiotensin II type 2 receptor. Biochem. Biophys. Res. Commun. 197: 393-99
86. Pucell AG, Hodges JC, Sen I, Bumpus FM, Husain A. 1991. Biochemical properties of the ovarian granulosa cell type 2-angiotensin II receptor. Endocrinology 128:1947-59
87. Ichiki T, Inagami T. 1995. Expression, genomic organization, and transcription of the mouse angiotensin II type 2 receptor gene. Circ. Res. 76:693-700
88. Ichiki T, Inagami T. 1995. Transcriptional regulation of the mouse angiotensin II type 2 receptor gene. Hypertension 25:720-25
89. Koike G, Horiuchi M, Yamada T, Szpirer C, Jacob HJ, Dzau VJ. 1994. Human type 2 angiotensin II receptor gene: cloned, mapped to the X chromosome, and its mRNA is expressed in the human lung. Biochem. Biophys. Res. Commun. 203:1842-50
90. 2) in rat brain. Am. J. Physiol. 261: R209-16
91. 2 receptors in the developing rat fetus. J. Clin. Invest. 88: 921-33
92. Feuillan PP, Millan MA, Aguilera G. 1993. Angiotensin II binding sites in the rat fetus: characterization of receptor subtypes and interaction with guanyl nucleotides. Regul. Pept. 44:159-69
93. Viswanathan M, Tsutsumi K, Correa FM, Saavedra JM. 1991 Changes in expression of angiotensin receptor subtypes in the rat aorta during development. Biochem. Biophys. Res. Commun. 179:1361-67
94. Sumners C, Myers LM. 1991. Angiotensin II decreases cGMP levels in neuronal cultures from rat brain. Am. J. Physiol. 260:C79-C87
95. 2 receptor stimulates protein tyrosine phosphatase activity and mediates inhibition of particulate guanylate cyclase. Biochem. Biophys. Res. Commun. 183:206-11
96. 1)- and angiotensin-II type-2 (AT2)-receptor-mediated changes in potassium currents in cultured neurons: role of intracellular calcium. FASEB J. 6:1012 (Abstr.)
97. Chaki S, Inagami T. 1992. Identification and characterization of a new binding site for angiotensin II in mouse neuroblastoma neuro-2A cells. Biochem. Biophys. Res. Commun. 182:388-94
98. Chaki S, Inagami T. 1993. New signaling mechanism of angiotensin II in neuroblastoma neuro-2A cells: activation of soluble guanylyl cyclase via nitric oxide synthesis. Mol. Pharmacol. 43:603-8
99. 4 receptors: specificity and distribution. Kidney Int. 46:1510-12
100. 4 receptors in bovine adrenal cortex. Peptides 15:1037-44
101. Swanson GN, Hanesworth JM, Sardinia MF, Coleman JK, Wright JW, et al. 1992. Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor. Regul. Pept. 40:409-19
102. Le Noble FA, Schreurs NH, van Straaten HW, Slaaf DW, Smits JF, et al. 1993. Evidence for a novel angiotensin II receptor involved in angiogenesis in chick embryo chorioallantoic membrane. Am. J. Physiol. 264:R460-65
103. Gray DA, Gerstberger R, Simon E. 1989. Role of angiotensin II in aldosterone regulation in the Pekin duck. J. Endocrinol. 123:445-52
104. Murphy TJ, Nakamura Y, Takeuchi K, Alexander RW. 1993. A cloned angiotensin receptor isoform from the turkey adrenal gland is pharmacologically distinct from mammalian angiotensin receptors. Mol. Pharmacol. 44:1-7
105. 2 receptor subtypes. FEBS Lett. 284:281-84
106. Bergsma DJ, Ellis C, Nuthulaganti P, Nakao R, Yanase T, et al. 1993. Isolation and expression of a novel angiotensin II receptor from Xenopus laevis heart. Mol. Pharmacol. 44:277-84
107. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, et al. 1995. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc. Natl. Acad. Sci. USA 92:3521-25
108. Wong PC, Price WA Jr, Chiu AT, Duncia JV, Carini DJ, et al. 1990. Nonpeptide angiotensin-II antagonists. 11. Pharmacology of Exp3174, an active metabolite of DuP753, an orally active antihypertensive agent. J. Pharmacol. Exp. Ther. 255:211-17
109. Gradman AH, Arcuri KE, Goldberg AI, Ikeda LS, Nelson EB, et al. 1995. A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension. Hypertension 25: 1345-50
110. Bumier M, Waeber B, Brunner HR. 1994. The advantages of angiotensin II antagonism. J. Hypertens. 12:S7-S15
111. Rolfs A, Kallisch H, Weber I. Regitz-Zagrosek V, Fleck E. 1994. Mn/I polymorphism for the AGTR1 gene. Hum. Mol. Genet. 3:213
112. Doria A, Ji L, Warram JH, Krolewski AS. 1994. Ddel polymorphism in the AGTR1 gene. Hum. Mol. Genet. 3:1444
113. Curnow KM, Pascoe L, White PC. 1992. Genetic analysis of human type-1 angiotensin II receptor. Mol. Endocrinol. 6:1113-18
114. Bonnardeaux A, Davies E, Jeunemailre X, Fery I, Charru A, et al. 1994. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 24:63-69
115. Powell JS, Clozel J-P, Muller RKM, Kuhn H, Hefti F, et al. 1989. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 245:186-88
116. 1 receptor antagonist. Am. J. Pathol. 139: 1291-96
117. Hanson SR, Powell JS, Dodson T, Lumsden A, Kelly AB, et al. 1991. Effects of angiotensin converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboon. Hypertension 18(Suppl. II):II70-76
118. MERCATOR Study Group. 1992. The multicenter European research trial with cilazapril after angioplasty to prevent transluminal coronary obstruction and restenosis MERCATOR study group. Circulation 86:100-10
119. Linz W, Schoelkens BA, Ganten D. 1989. Converting enzyme inhibition specifically prevents the development and induces the regression of cardiac hypertrophy in rats. Clin. Exp. Hypertens. A 11:1325-50
120. Lindpaintner K, Ganten D. I991. The cardiac renin-angiotensin system: a synopsis of current experimental and clinical data. Acta Cardiol. 46:385-97
121. Khairallah PA, Robertson AL, Davila D. 1972. Effect of angiotensin II on DNA, RNA, and protein synthesis. In Hypertension, ed. J Genest, E Krow, pp. 212-20. New York: Springer-Verlag
122. Tan LB, Brilla C, Weber KT. 1992. Prevention of structural changes in the heart in hypertension by ACE inhibition. J. Hypertens. 10(Suppl. 1):S31-S34
123. Kim S, Ohta K, Hamaguchi A, Yukimura T, Miura K, Iwao H. 1995. Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats. Hypertension 25:1252-59
124. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, et al. 1992. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-44
125. Tiret L, Bonnardeaux A, Poirier O, Ricard S, Marques-Vidal P, et al. 1994. Synergistic effects of angiotensin converting enzyme and angiotensin II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 344: 910-13
126. Pfeffer MA, Braunwald E. 1990. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81: 1161-72
127. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. 1985. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopnl. Circulation 72:406-12
128. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. 1988. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N. Engl. J. Med. 319:80-86
129. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, et al. 1992. Effect of captopril on morbidity and mortality in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 327:669-77
130. Konstam MA, Rousseau MF, Kronenberg MW, Udelson JE, Melin J, et al. 1992. Effects of angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. Circulation 86:431-38
131. Reiss K, Capasso JM, Huang H, Meggs LG, Li P, Anversa P. 1993. Ang II receptors, c-myc, and c-jun in myocytes after myocardial infarction and ventricular failure. Am. J. Physiol. 264:H760-69
132. Conn JN, Johnson G, Ziesche S. 1991. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N. Engl. J. Med. 325:303-10
133. Crozier I, Ikram H, Awan N, Cleland J, Stephen N, et al. 1995. Losartan in heart failure. Hemodynamic effects and tolerability. Circulation 91:691-97
134. 2 receptors in the rat brain. Mol. Pharmacol. 41:290-97
135. 11 α-subunits in cultured vascular smooth muscle cells. Mol. Pharmacol. Toxicol. In press